Trademark: 87414967
Word
VETPRP
Status
Registered
Status Code
700
Status Date
Tuesday, July 30, 2019
Serial Number
87414967
Registration Number
5823515
Registration Date
Tuesday, July 30, 2019
Mark Type
4000
Filing Date
Tuesday, April 18, 2017

Trademark Owner History
RegenLab USA LLC - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use
10 Medical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; suture material; cases fitted for medical instruments; receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels

Trademark Events
Mar 27, 2023
Teas Change Of Correspondence Received
Mar 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 10, 2023
Teas Change Of Correspondence Received
Jan 10, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 13, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 13, 2020
Teas Change Of Correspondence Received
Oct 13, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 13, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 13, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 13, 2020
Teas Change Of Owner Address Received
Jul 30, 2019
Registered-Supplemental Register
Jun 26, 2019
Law Office Publication Review Completed
Jun 20, 2019
Assigned To Lie
Jun 14, 2019
Approved For Registration Supplemental Register
Jun 10, 2019
Teas/Email Correspondence Entered
Jun 4, 2019
Correspondence Received In Law Office
Jun 10, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 10, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 4, 2019
Teas Response To Office Action Received
Feb 21, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 21, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 9, 2019
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Feb 8, 2019
Notification Of Non-Final Action E-Mailed
Feb 8, 2019
Non-Final Action E-Mailed
Feb 8, 2019
Non-Final Action Written
Feb 8, 2019
Use Amendment Accepted
Jan 19, 2019
Teas/Email Correspondence Entered
Jan 18, 2019
Correspondence Received In Law Office
Jan 18, 2019
Teas Request For Reconsideration Received
Jan 19, 2019
Amendment To Use Processing Complete
Jan 19, 2019
Use Amendment Filed
Jan 18, 2019
Teas Amendment Of Use Received
Oct 1, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 1, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 20, 2018
Notification Of Final Refusal Emailed
Jul 20, 2018
Final Refusal E-Mailed
Jul 20, 2018
Final Refusal Written
Jul 3, 2018
Suspension Checked ¿ To Attorney For Action
Jun 29, 2018
Assigned To Lie
Dec 8, 2017
Notification Of Letter Of Suspension E-Mailed
Dec 8, 2017
Letter Of Suspension E-Mailed
Dec 8, 2017
Suspension Letter Written
Nov 27, 2017
Teas/Email Correspondence Entered
Nov 27, 2017
Correspondence Received In Law Office
Nov 27, 2017
Teas Response To Office Action Received
Jul 14, 2017
Notification Of Non-Final Action E-Mailed
Jul 14, 2017
Non-Final Action E-Mailed
Jul 14, 2017
Non-Final Action Written
Jul 10, 2017
Assigned To Examiner
Apr 24, 2017
New Application Office Supplied Data Entered
Apr 21, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24